Zepp Health (NYSE:ZEPP) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Zepp Health (NYSE:ZEPP) from a sell rating to a hold rating in a research note issued to investors on Saturday.

Separately, Fundamental Research set a $56.28 target price on shares of Zepp Health and gave the stock a “buy” rating in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Zepp Health presently has an average rating of “Hold” and a consensus target price of $56.28.

Zepp Health Price Performance

Shares of NYSE ZEPP opened at $5.29 on Friday. The firm has a 50-day simple moving average of $6.41 and a 200-day simple moving average of $14.53. The company has a quick ratio of 0.67, a current ratio of 0.88 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $77.73 million, a price-to-earnings ratio of -2.10 and a beta of 1.83. Zepp Health has a 52 week low of $3.85 and a 52 week high of $61.85.

Insider Buying and Selling at Zepp Health

In other news, CFO Cheng Deng sold 9,836 shares of the business’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $4.61, for a total transaction of $45,343.96. Following the transaction, the chief financial officer owned 114,539 shares of the company’s stock, valued at approximately $528,024.79. The trade was a 7.91% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 36.00% of the company’s stock.

Hedge Funds Weigh In On Zepp Health

Institutional investors have recently bought and sold shares of the company. Public Employees Retirement System of Ohio grew its position in Zepp Health by 61.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock worth $41,000 after acquiring an additional 576 shares during the period. Harvest Fund Management Co. Ltd lifted its stake in shares of Zepp Health by 6.7% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock valued at $1,207,000 after purchasing an additional 2,800 shares during the last quarter. Osaic Holdings Inc. lifted its stake in shares of Zepp Health by 239.5% in the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after purchasing an additional 5,845 shares during the last quarter. Dimensional Fund Advisors LP purchased a new position in shares of Zepp Health during the 4th quarter worth $241,000. Finally, Capstone Capital Management Ltd acquired a new stake in shares of Zepp Health during the 4th quarter worth about $298,000. 52.61% of the stock is owned by hedge funds and other institutional investors.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.